Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (591-600 of 622) with videos related to

Pageof 63
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Rheumatology (Oxford, England)|May 13, 2017
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR groupVeronika K Jaeger, Oliver Distler, Britta Maurer, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueJoerg H W Distler, Suzana Jordan, Paolo Airo, et al.
Autoimmunity Reviews|December 16, 2020
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' ConsensusRoberto Giacomelli, Antonella Afeltra, Elena Bartoloni, et al.
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.
Rheumatology (Oxford, England)|September 26, 2024
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD datasetMarco Fornaro, Vincenzo Venerito, Maria Rosa Pellico, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Annals of the Rheumatic Diseases|April 11, 2019
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort studyMuriel Elhai, Marouane Boubaya, Oliver Distler, et al.
Pageof 63

Showing results (591-600 of 622) with videos related to

Sort By:
Pageof 63
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2019
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialDinesh Khanna, Cathie Spino, Sindhu Johnson, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
Rheumatology (Oxford, England)|May 13, 2017
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR groupVeronika K Jaeger, Oliver Distler, Britta Maurer, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi techniqueJoerg H W Distler, Suzana Jordan, Paolo Airo, et al.
Autoimmunity Reviews|December 16, 2020
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' ConsensusRoberto Giacomelli, Antonella Afeltra, Elena Bartoloni, et al.
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
The Lancet. Respiratory Medicine|July 1, 2022
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysisMarius M Hoeper, Krit Dwivedi, Christine Pausch, et al.
Rheumatology (Oxford, England)|September 26, 2024
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD datasetMarco Fornaro, Vincenzo Venerito, Maria Rosa Pellico, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 21, 2020
Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registryMarius M Hoeper, Christine Pausch, Ekkehard Grünig, et al.
Annals of the Rheumatic Diseases|April 11, 2019
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort studyMuriel Elhai, Marouane Boubaya, Oliver Distler, et al.
Pageof 63